Lumida
/IRWD
⌘K
Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc

IRWD
$4.08USD↑+2.77%+0.11 today

MARKET CAP

674.2M

P/E (TTM)

5.1x

FWD P/E

3.1x

DAY RANGE

$4 – $4

52W RANGE

$1
$6

AI Summary

Stalk
StalkMedium

IRWD remains in a Stage 2 advancing context with price consolidating near the rising 200-day SMA. Medium-term bias stays bullish, but short-term momentum is negative as price trades below the 9/20-day EMA cluster. Execution is deferred: stalk long on pullbacks into the 9/20 EMA zone (~4.15–4.18) or holds at the 200-day SMA (~3.95). The long-term uptrend on the rising 200-day SMA remains intact; a sustained break below that level would invalidate the bullish view.

  • ↑Q2 revenue $113M up 33% YoY, driven by Linzess’s 14% sales jump to $282.3M.
  • ↑Full-year Linzess net sales guidance raised to $1.15–$1.20B on mid-single-digit demand growth.
  • ↓Revenue tied almost exclusively to Linzess, exposing cash flow to demand swings.
Full analysis →
Insider Trades39 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Jul 7, 2026SellIRWDRonald SilverPFO & PAO127,890$4.52$674.2M-29.41%+254.78%$578.1K-28.96%10b5-1Buy Now
Feb 23, 2026SellIRWDTammi L GaskinsChief Commercial Officer21,526$3.73$674.2M-29.41%+254.78%$80.3K-4.68%—Buy Now
Feb 23, 2026SellIRWDGregory S. MartiniChief Financial Officer21,944$3.73$674.2M-29.41%+254.78%$81.9K-6.19%—Buy Now
Feb 23, 2026SellIRWDRonald SilverPrincipal Accounting Officer24,173$3.73$674.2M-29.41%+254.78%$90.2K-4.46%—Buy Now
Feb 23, 2026SellIRWDMichael ShetzlineSVP, CMO, Head-Res&Drug32,582$3.73$674.2M-29.41%+254.78%$121.6K-2.98%—Buy Now
Feb 23, 2026SellIRWDMinardo JohnChief Legal Officer36,492$3.73$674.2M-29.41%+254.78%$136.2K-4.66%—Buy Now
Feb 23, 2026SellIRWDThomas A MccourtChief Executive Officer198,283$3.73$674.2M-29.41%+254.78%$739.9K-6.05%—Buy Now
Jan 5, 2026SellIRWDRonald SilverPrincipal Accounting Officer35,416$4.60$674.2M-29.41%+254.78%$162.9K-11.34%10b5-1Buy Now
Nov 17, 2025SellIRWDTammi L GaskinsChief Commercial Officer6,016$3.32$674.2M-29.41%+254.78%$20.0K-2.49%—Buy Now
Aug 11, 2025SellIRWDGregory S. MartiniChief Financial Officer1,265$0.84$674.2M-29.41%+254.78%$1.1K-0.69%—Buy Now
Aug 11, 2025SellIRWDTammi L GaskinsChief Commercial Officer1,316$0.84$674.2M-29.41%+254.78%$1.1K-0.54%—Buy Now
Aug 11, 2025SellIRWDRonald SilverPrincipal Accounting Officer2,846$0.84$674.2M-29.41%+254.78%$2.4K-1.02%—Buy Now
Aug 11, 2025SellIRWDMinardo JohnChief Legal Officer7,754$0.84$674.2M-29.41%+254.78%$6.5K-1.90%—Buy Now
May 16, 2025SellIRWDTammi L GaskinsChief Commercial Officer2,563$0.58$674.2M-29.41%+254.78%$1.5K-1.05%—Buy Now
May 16, 2025SellIRWDThomas A MccourtChief Executive Officer13,353$0.58$674.2M-29.41%+254.78%$7.7K-1.15%—Buy Now
Feb 10, 2025SellIRWDRonald SilverPrincipal Accounting Officer12,048$1.76$674.2M-29.41%+254.78%$21.2K-4.13%—Buy Now
Feb 10, 2025SellIRWDGregory S. MartiniChief Financial Officer12,052$1.76$674.2M-29.41%+254.78%$21.2K-6.15%—Buy Now
Feb 10, 2025SellIRWDMinardo JohnChief Legal Officer38,938$1.76$674.2M-29.41%+254.78%$68.5K-8.71%—Buy Now
Feb 10, 2025SellIRWDMichael ShetzlineSVP, CMO, Head-Res&Drug41,269$1.76$674.2M-29.41%+254.78%$72.6K-6.93%—Buy Now
Feb 10, 2025SellIRWDThomas A MccourtChief Executive Officer139,064$1.76$674.2M-29.41%+254.78%$244.8K-10.70%—Buy Now
Nov 18, 2024SellIRWDAndrew DavisSVP, Chief Business Officer5,360$4.08$674.2M-29.41%+254.78%$21.9K-1.85%—Buy Now
Nov 18, 2024SellIRWDSravan Kumar EmanySVP, COO and CFO11,001$4.08$674.2M-29.41%+254.78%$44.9K-3.43%—Buy Now
Aug 12, 2024SellIRWDRonald SilverPrincipal Accounting Officer3,107$4.27$674.2M-29.41%+254.78%$13.3K-1.92%—Buy Now
Aug 12, 2024SellIRWDMinardo JohnChief Legal Officer9,910$4.27$674.2M-29.41%+254.78%$42.3K-3.36%—Buy Now
May 20, 2024SellIRWDMichael ShetzlineCMO,SVP,Head-Res&Drug16,128$6.45$674.2M-29.41%+254.78%$104.0K-3.75%—Buy Now
May 20, 2024SellIRWDMinardo JohnChief Legal Officer17,404$6.45$674.2M-29.41%+254.78%$112.3K-5.58%—Buy Now
May 20, 2024SellIRWDAndrew DavisSVP, Chief Business Officer22,725$6.45$674.2M-29.41%+254.78%$146.6K-7.31%—Buy Now
May 20, 2024SellIRWDThomas A MccourtChief Executive Officer67,618$6.45$674.2M-29.41%+254.78%$436.1K-5.55%—Buy Now
May 16, 2024SellIRWDSravan Kumar EmanySVP, Chief Financial Officer18,280$6.64$674.2M-29.41%+254.78%$121.4K-5.39%—Buy Now
Mar 4, 2024BuyIRWDSravan Kumar EmanySVP, Chief Financial Officer10,684$9.38$674.2M-29.41%+254.78%$100.2K+3.67%—Buy Now
Feb 12, 2024SellIRWDRonald SilverPrincipal Accounting Officer7,908$15.24$674.2M-29.41%+254.78%$120.5K-5.56%—Buy Now
Feb 12, 2024SellIRWDAndrew DavisSVP, Chief Business Officer9,846$15.24$674.2M-29.41%+254.78%$150.1K-3.93%—Buy Now
Feb 12, 2024SellIRWDMichael ShetzlineCMO,SVP,Head-Res&Drug38,618$15.24$674.2M-29.41%+254.78%$588.5K-9.50%—Buy Now
Feb 12, 2024SellIRWDMinardo JohnChief Legal Officer47,380$15.24$674.2M-29.41%+254.78%$722.1K-15.83%—Buy Now
Feb 12, 2024SellIRWDThomas A MccourtChief Executive Officer177,164$15.24$674.2M-29.41%+254.78%$2.7M-17.54%—Buy Now
Feb 8, 2024SellIRWDSravan Kumar EmanySVP, Chief Financial Officer41,332$14.90$674.2M-29.41%+254.78%$615.8K-15.48%—Buy Now
Nov 20, 2023SellIRWDAndrew DavisSVP, Chief Business Officer3,287$9.69$674.2M-29.41%+254.78%$31.9K-1.49%—Buy Now
Nov 16, 2023SellIRWDSravan Kumar EmanySVP, Chief Financial Officer6,661$9.44$674.2M-29.41%+254.78%$62.9K-3.53%—Buy Now
Sep 15, 2023BuyIRWDSravan Kumar EmanySVP, Chief Financial Officer36,072$8.32$674.2M-29.41%+254.78%$300.1K+23.63%—Buy Now